Myriad Uranium Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$6.0 Million

[vc_row][vc_column][vc_column_text css=”.vc_custom_1762139738889{margin-bottom: 0px !important;}”]Vancouver, British Columbia – November 3, 2025 – Myriad Uranium Corp. (CSE: M) (FSE: C3Q) (“Myriad” or the “Company”) is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc. (“Red Cloud”), as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, (collectively, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase for resale 15,000,000 units of the Company (the “Units”) at a price of C$0.40 per Unit (the “Offering Price”) on a “bought deal” private placement basis for gross proceeds of C$6,000,000 (the “Underwritten Offering”).

Each Unit will consist of one common share of the Company (each, a “Unit Share”) and one common share purchase warrant of the Company (each, a “Warrant”). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a “Warrant Share”) at a price of C$0.60 per Warrant Share at any time on or following the date that is 61 days following the Closing Date (as defined herein) to the date that is on or before that date which is 36 months after the Closing Date.

The Company has granted the Underwriters an option, exercisable up to 48 hours prior to the Closing Date, to purchase for resale up to an additional 2,500,000 Units at the Offering Price for additional gross proceeds of up to C$1,000,000 (the “Over-Allotment Option”, and together with the Underwritten Offering, the “Offering”).

The Company intends to use the net proceeds from the Offering for the exploration and advancement of the Company’s Copper Mountain Uranium Project in Wyoming, U.S. and Red Basin Project in New Mexico, U.S., as well as for general corporate purposes and working capital.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), the Units under the Offering will be offered for sale to eligible substituted purchasers resident in the provinces of British Columbia, Alberta, Manitoba, Saskatchewan and Ontario (and, with the consent of the Company, in Québec) pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “Listed Issuer Financing Exemption”). The Unit Shares and Warrants underlying the Units, and the Warrant Shares underlying the Warrants, if exercised, are expected to be immediately freely tradeable under applicable Canadian securities legislation. The Units may also be sold in offshore jurisdictions and in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act”).